Impact of TAVI on Cognition, Mood and Health-related Quality of Life
NCT ID: NCT04371172
Last Updated: 2023-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
128 participants
OBSERVATIONAL
2023-02-20
2025-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions
NCT05464472
Neuropsychological and Neuroimaging Evaluation of the Cognitive Impairment in Aortic Valve Replacement (ARTiCO)
NCT05235529
Cognitive Outcome After Surgical and Transcatheter Aortic Valve Replacement
NCT04535076
Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT05614986
Impact of Pre-procedure Cognitive Status on Outcome at 3 Months After Transcatheter Aortic Valve Implantation
NCT04564534
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the proposed study, patients with and without embolic protection devices during TAVI will be repeatedly examined with a comprehensive psychiatric and cognitive test battery over a post-interventional period of 6 months after TAVI, with regard to the effects on mood, cognitive Performance and health-related quality of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with TAVI
cognitive research battery, MRI, laboratory values
cognitive research battery, MRI, laboratory values
cognitive research battery, MRI, laboratory values
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cognitive research battery, MRI, laboratory values
cognitive research battery, MRI, laboratory values
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women and men between the ages of 19 and 90
* Clinical indication for TAVI intervention
* No previous psychiatric illness before TAVI
* No other serious disease affecting the immune system
* Persons unable to give consent (e.g. dementia, delirium etc.)
* Magnetic resonance imaging (MR) contraindications
* ophthalmological inability to read
19 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Baranyi
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Baranyi, Prof.
Role: PRINCIPAL_INVESTIGATOR
Medical University Graz, Austria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Graz
Graz, Styria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32-249 ex19/20
Identifier Type: OTHER
Identifier Source: secondary_id
32-249 ex 19/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.